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Abstract
Background: Ovine footrot caused by Dichelobacter nodosus (D nodosus) is an infectious disease affecting sheep
worldwide. Switzerland plans a nationwide footrot eradication program, based on PCR-testing of interdigital swab
samples. The aim of this study was to test for the presence of D nodosus in clinically footrot-free sheep flocks which
had been subjected to different treatment strategies, to assess whether they were feasible for the eradication
process, especially focussing on antimicrobial flock treatments. Clinical scoring and PCR-results were compared. Ten
farms had used hoof bathing and hoof trimming without causing bleeding, ten had used individual treatments and
flock vaccines to gain the free status and ten had become free through whole-flock systemic macrolide treatment.
For every farm, three risk-based collected pool samples were analysed for the occurrence of virulent and benign D
nodosus by PCR detection of aprV2/aprB2.
Results: Six flocks from any treatment group tested positive for aprB2 in all pools. Clinical signs were absent at the
time of sampling, but some flocks had experienced non-progressive interdigital inflammation previously. Two flocks
tested aprV2-positive in the high-risk pool. One of them underwent a progressive footrot outbreak shortly after
sampling. Individual retesting indicated, that virulent D nodosus most likely was reintroduced by a recently
purchased ram. In the second flock, a ram was tested positive and treated before clinical signs occurred.
Conclusions: All treatment strategies eliminated the causative agent and were found to be suitable for
implementation in the PCR-based eradication process. PCR-testing proved to be more sensitive than visual scoring,
as it also detected clinically healthy carriers. It will be of benefit as a diagnostic tool in elimination and surveillance
programs.
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Background
Ovine footrot is a bacterial infection of the interdigital
skin of sheep challenging producers worldwide [1]. It is
characterised by a strong odour and an exudative inflam-
mation which leads to epidermal necrosis and, in severe
cases, separation of the hoof horn capsule from the
underlying dermal tissue [2]. This highly painful disease
causes severe lameness and is therefore a serious animal
welfare issue in sheep-producing countries [3–5]. Further-
more, it leads to financial losses in meat, milk and wool
production due to poor ewe fertility, lower lamb growth
rates and reduced sales opportunities for infected livestock
[4, 6, 7]. The essential causative agent of footrot is Diche-
lobacter nodosus (D nodosus), a Gram-negative, anaerobic
bacterium which thrives in moist and warm environmen-
tal conditions [8, 9].
D nodosus isolates can be categorised as either benign
or virulent by their expression of the aprB2 and aprV2
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gene, respectively, which code for thermolabile or thermo-
stable acidic proteases [10]. They are important enzymes in
the characteristic tissue-destructive pathogenesis of footrot
and are assumed to be the key virulence factors of D nodo-
sus [11–13]. Virulent strains lead to severe lameness with
the typical underrunning of the hoof horn (clinical footrot),
while benign strains tend to cause non-progressive inflam-
mation of the interdigital skin (interdigital dermatitis). In
this paper, the term clinical footrot is used for severe in-
flammation which is not restricted to the interdigital space
and includes progressive underrunning of the horn capsule
(score > 2) contrarily to interdigital dermatitis (score 1–2).
For differentiation, the scoring system of the Swiss Consult-
ing and Health Service for Small Ruminants was used [14].
As early stages of footrot cannot be distinguished from
other interdigital infections by clinical signs alone [15], the
development of appropriate diagnostic tools is important
[1]. Stäuble et al. [10] implemented a real-time PCR, which
enables early simultaneous detection and discrimination of
aprB2 and aprV2 positive strains directly from clinical
samples.
Footrot is the economically most relevant infectious
hoof disease in sheep [16]. Cost-benefit-analyses support
elimination programs to obliterate the disease [14, 17, 18].
Different treatment strategies have been assessed all over
the world, ranging from total elimination of the causative
agent by culling infected flocks to genetic selection of
resistant animals and use of specific vaccines [19, 20].
Antimicrobial whole-flock treatments deliver promising
results throughout Europe in terms of elimination of clin-
ically apparent footrot [17, 21, 22], but are also criticised
regarding the emerging antimicrobial resistance in human
and veterinary medicine. Gamithromycin, a macrolide of
the azalide subclass, has been licensed for the treatment of
footrot in sheep in Germany and other European coun-
tries since 2017. It is well suited for antimicrobial elimin-
ation of footrot due to clinical cure rates of more than
90% after a single injection [23] and due to its user-
friendliness. In addition, it has no known side effects for
the animal, concentrates in skin and inflamed tissue and
therapeutic concentrations in the hoof are maintained,
with a half-life of 5.25 days [24].
The objective of the present study was to find out
whether sheep flocks which became clinically free from
footrot after a single antimicrobial whole flock treatment
with macrolides were also free from virulent D nodosus
as tested by real-time PCR of pooled swab samples
(group C). This was compared with PCR-results from
flocks which had been clinically free from footrot for a
period of 10 years or more and had used footbathing and
hoof trimming without causing bleeding (group A) and
to flocks which had become clinically free at least 2
years before sampling, following a protocol including
foot-bathing, topical and/or systemic application of
antimicrobials and vaccination with a commercial vac-
cine (group B). Furthermore, the possible benefits of a
PCR-based footrot elimination program compared with
an elimination protocol based on clinical signs were
assessed.
Results
Seven sheep from three different flocks (three animals on
farm 7, two animals on farm 9 and two animals on farm
15) had a footrot score of 1 (mild interdigital inflamma-
tion), whilst the rest scored 0. Table 1 shows the PCR-
outcome for the pooled flock samples, grouped according
to their treatment strategy.
Only two flocks (farm 9 (group C) and farm 24 (group
B)) tested positive for virulent D nodosus (aprV2-posi-
tive), and in both cases, only the high-risk pools were
positive. On farm 9, two animals of the positive pool had
a footrot score of 1, while the rest of this flock was
scored 0, just as all ten sheep in the positive high-risk
pool of farm 24 did (Table 2).
Benign D nodosus (aprB2-positive) was found in six
flocks and always in all three pools. All animals in the posi-
tive pools had a footrot score of 0. In group A, three farms
tested positive (farm 14, 21 and 29), in group B there were
two farms (farm 18 and 25) and in group C only a single
farm tested positive (farm 9) for the aprB2 gene.
Four pools were selected for analysis of single animal
samples. Two of these were the high-risk pools of farms
9 and 24, which had been tested positive for virulent D
nodosus. Table 2 shows the results of the individually
tested samples. In pool 1 of farm 9 (group C), several
combinations were found: Two animals were only posi-
tive for aprV2. They had both scored 1 in the clinical
footrot score. Four animals were only positive for aprB2,
and four were positive for both alleles. Those eight
animals had scored 0 when clinically examined. When in-
vestigating for detailed information about the pool group,
it was found, that one of the two only aprV2-positive
samples with the score 1 was from a recently purchased
ram. Two weeks after sampling, the flock had a footrot
outbreak with progressive clinical signs.
Pool 1 of farm 24 revealed the following results when
single samples were tested: only one animal tested posi-
tive for aprV2. The other samples were negative for D
nodosus. The whole group had a score 0 when sampled.
Further investigations on the farm resulted in the infor-
mation, that the positive animal, a ram, was newly pur-
chased and recently introduced into the flock. The ram
still scored 0 as well as the rest of the flock at the next
veterinary farm visit 18 days later, but the ram was sepa-
rated from the flock after the positive result was given,
and he was treated with gamithromycin as a biosecurity
measure and due to animal welfare reasons.
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The other retested samples were the high-risk pools of
farms 22 and 23 since they showed exceptionally high
Ct-values of up to 38 in the internal positive control
(IPC) in all pool groups indicative for the presence of
PCR inhibitors in the pool samples. However, tested sin-
gle samples of the high-risk pools confirmed the nega-
tive results for these farms.
All farms were regularly revisited by the farm vet (at
least once every 3 months). The farms lameness score
was assessed at all visits. A regular hoof screening was
performed by the farmer at routine hoof trimming. Every
sheep and every hoof was inspected. All farms stayed
clinically healthy for the observed period of 12 months
after the samples were taken, excluding farm 9.
Discussion
The present study demonstrates that antimicrobial
whole-flock treatments, combined with footbathing, can
be a useful tool to eliminate both clinical signs of footrot
and the causative agent, i.e. virulent D nodosus. This
makes antimicrobial treatments applicable for elimination
programs based on PCR results, always under consider-
ation of the disadvantages of using critically important an-
timicrobials. Real-time PCR testing proved to be a more
sensitive method than clinical examination, as it also iden-
tified clinically healthy carriers of D nodosus.
Ideally, samples would have been collected before the
elimination process as well, however this was not an ex-
perimental but a field study. It remains unclear, whether
Table 1 Pooled sample PCR-results for farms 1–30, grouped according to the chosen treatment method
Group Farm
number
Flock
size
Footrot free
since
Pool 1–10 Pool 11–20 Pool 21–30
aprV2 aprB2 aprV2 aprB2 aprV2 aprB2
A 6 700 before 2008 neg. neg. neg. neg. neg. neg.
13 400 neg. neg. neg. neg. neg. neg.
14 1000 neg. pos. ct36 neg. pos. ct26 neg. pos. ct30
20 800 neg. neg. neg. neg. neg. neg.
21 250 neg. pos. ct22 neg. pos. ct27 neg. pos. ct27
26 950 neg. neg. neg. neg. neg. neg.
27 750 neg. neg. neg. neg. neg. neg.
28 150 neg. neg. neg. neg. neg. neg.
29 650 neg. pos. ct24 neg. pos. ct30 neg. pos. ct28
30 250 neg. neg. neg. neg. neg. neg.
B 1 800 2015 neg. neg. neg. neg. neg. neg.
2 2800 2016 neg. neg. neg. neg. neg. neg.
3 800 2014 neg. neg. neg. neg. neg. neg.
5 750 2010 neg. neg. neg. neg. neg. neg.
12 850 2015 neg. neg. neg. neg. neg. neg.
16 550 2013 neg. neg. neg. neg. neg. neg.
17 600 2015 neg. neg. neg. neg. neg. neg.
18 600 2012 neg. pos. ct27 neg. pos. ct29 neg. pos. ct32
24 120 2013 pos. ct35 neg. neg. neg. neg. neg.
25 100 2016 neg. pos. ct35 neg. pos. ct24 neg. pos. ct26
C 4 70 2014 neg. neg. neg. neg. neg. neg.
7 850 2015 neg. neg. neg. neg. neg. neg.
8 650 2014 neg. neg. neg. neg. neg. neg.
9 1100 2015 pos. ct22 pos. ct23 neg. pos. ct24 neg. pos. ct24
10 150 2011 neg. neg. neg. neg. neg. neg.
11 900 2014 neg. neg. neg. neg. neg. neg.
15 800 2014 neg. neg. neg. neg. neg. neg.
19 450 2011 neg. neg. neg. neg. neg. neg.
22 250 2017 neg. neg. neg. neg. neg. neg.
23 400 2017 neg. neg. neg. neg. neg. neg.
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the aprB2-positive farms never eliminated benign D
nodosus in their flocks, due to healthy carriers which
never received any treatments, or whether the farmers
introduced purchased carriers without clinical signs to
the flock which again spread the agent. The latter can be
assumed likely in flock 9, as whole flock antimicrobial treat-
ments eliminate both genotypes, and the biosecurity deficits
regarding the new outbreak support this hypothesis.
The risk-based pool-of-10 sampling strategy worked
well in our setting, since all animals positive for virulent
D nodosus were found in the high-risk group. Pooling
and pool size were found to be reliable and appropriate.
This supports the application of risk-based pooling for
flock screenings, elimination and surveillance programs,
as it is cost and labour effective.
One major challenge in footrot elimination is the de-
velopment of diagnostic tests which can discriminate re-
liably between target and non-target strains [1]. Regional
elimination programs are usually aimed at virulent D
nodosus, as large-scale elimination of benign D nodosus
is not economically justifiable [25]. In Switzerland, the
use of the PCR test was found to be the most economic
and sensitive way to eliminate footrot in the planned
nationwide control program [18]. Moreover, the PCR
test can be applied to other ruminants like goats and
cattle or camelids, which is important for targeted dis-
ease control [26]. In the current study, it detected
symptomless carriers of virulent and benign D nodosus
before clinical signs were manifest and proved thereby
to be more sensitive than clinical scoring. The PCR re-
sults agreed with the clinical appearance of virulent and
benign strains, including subclinical carriers, in agree-
ment with previous observations [10, 27, 28]. Virulent D
nodosus caused progressive underrunning footrot in
flock 9 during the outbreak that followed sampling.
When the farmer discovered the reinfection, 20% of the
flock was already infected and had to be treated. Two
weeks earlier, also the farm of origin of the infected ram
had noticed a new footrot outbreak.
In flock 24, no clinical signs were observed when the
flock was revisited 3 weeks later. It must be noted that
the single positive animal in that flock was again the
ram. It had a low load of virulent D nodosus based on
the high Ct-value and underwent immediate antimicro-
bial treatment, once the positive result was known.
Likewise, there were no clinical signs in the flocks
positive for benign D nodosus at the time of sampling,
probably due to dry weather conditions. According to
the flock health veterinarian, aprB2-positive D nodosus
occasionally caused either mild inflammations (likely in
lambs due to increased vulnerability of their interdigital
space in rough conditions) or severe inflammations with
acute lameness, but no underrunning (H. Strobel, per-
sonal communication). It can be concluded that clinical
Table 2 Individual footrot scores and PCR-results of the sheep in the two aprV2-positive pool groups
Farm number Sample number Sex Footrot score aprV2 aprB2
9 9/01 male 1 pos. ct19 neg.
9/02 male 1 pos. ct28 neg.
9/03 male 0 pos. ct20 pos. ct26
9/04 female 0 pos. ct29 pos. ct26
9/05 female 0 neg. pos. ct24
9/06 female 0 pos. ct38 pos. ct27
9/07 female 0 neg. pos. ct24
9/08 female 0 pos. ct36 pos. ct26
9/09 female 0 neg. pos. ct26
9/10 female 0 neg. pos. ct24
24 24/01 male 0 pos. ct36 neg.
24/02 female 0 neg. neg.
24/03 female 0 neg. neg.
24/04 female 0 neg. neg.
24/05 female 0 neg. neg.
24/06 female 0 neg. neg.
24/07 female 0 neg. neg.
24/08 female 0 neg. neg.
24/09 female 0 neg. neg.
24/10 female 0 neg. neg.
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features are consistent with the PCR classification if benign
is defined as non-progressive in the South German sheep
population. This is in line with findings from Locher et al.
[27] in a previous study on clinically free sheep flocks in
Switzerland, was described in Australia by Best et al. [29]
and also reported from Norwegian farms by Vatn et al.
[28]. Further, Best et al. [29] proofed, that real-time PCR
was significantly more sensitive in detection of aprV2 in
clinically healthy sheep compared with culture/gelatinase
test. McPherson et al. stated, that the results of the real-
time PCR did not agree sufficiently with the clinical find-
ings in Australian sheep flocks and therefore depended on
additional culturing [30]. In Sweden benign D nodosus is
often associated with underrunning (score ≥ 3 lesions)
[31]. Similarly, clinical impact caused by benign D
nodosus was reported from a wild-range alpine ibex col-
ony in Switzerland [32]. Therefore, further research is
required to determine whether the PCR classification
used in this study corresponds to clinical presentation,
if considered as elimination tool in other species like
goats or other populations, since the genetic background
of the host also plays a role [33]. If clinical disease expres-
sion and PCR results match each other, the test is a useful
diagnostic tool for early diagnosis of virulent D nodosus at
the flock level and can support veterinarians to distinguish
between footrot and interdigital inflammations of other
cause at an early stage of disease, when clinical signs are
not definite [14]. This will lead to reduced antimicrobial
use, as non-progressive interdigital inflammations respond
well to alternative treatments.
Animal welfare is an important concern in today’s soci-
ety, and footrot is one of the main welfare issues in sheep
production [34]. Antimicrobial whole-flock treatments have
shown successful results for elimination of the disease [22].
Strobel et al. [23] reported cure rates of more than 99%
after one or two systemic administrations. Therefore, if a
single antimicrobial treatment can improve animal welfare
significantly, it should be considered [35]. On the other
hand, the World Health Organization considers the popu-
larly used macrolides as “critically important antimicro-
bials” for human medicine, and gives them highest priority
within this category, suggesting to restrict their use if alter-
native treatments are available [36]. This puts pressure
on veterinarians to limit antimicrobial use [37]. Before
implementing a footrot elimination program based on
antimicrobials, it must be investigated, whether strict
biosecurity measures can be fulfilled after the elimin-
ation to avoid reinfections, repeated antimicrobial
treatments and economic losses. Especially the farmer’s
engagement and will to eliminate the disease is mentioned
as a key factor for successful elimination [1, 29, 38], be-
sides culling of non-responders and strict quarantine of
purchased animals [15, 38]. Our study shows that moni-
toring the whole flock remains essential even after clinical
elimination, and the aprV2/aprB2 PCR is a very useful
tool for this purpose.
Whilst macrolide treatments are at present an effective
tool to eliminate virulent D nodosus, it is likely, that they
will no longer be licensed or effective in the future. Re-
peated footbathing in 10% ZnSO4 solution proved to be
effective for the elimination of virulent strains of D
nodosus in a proof-of-concept study [39]. However, since
the application of disinfectants based on zinc, copper or
formol solution is debatable, further investigation on al-
ternative foot bath solutions and alternative ways to treat
clinical footrot is desirable. The reintroduction of viru-
lent or benign D nodosus to a sanitized flock through a
clinically healthy carrier must be considered the main
risk [2], and was also described in a field study by Forbes
et al. [22]. Rams were found to be a major risk factor as
they often change hands and are being shown in sheep
markets. The establishment of a footrot free flock certifi-
cation, which is based on a negative PCR outcome for D
nodosus, as Stamphøj et al. [21] suggested, would allow
farmers to select rams from footrot free breeders, which
might be a key factor for footrot elimination in European
sheep production. Ram breeders would be obliged to join
in an accreditation scheme.
Conclusions
In conclusion, this study shows that a single macrolide
whole-flock treatment combined with footbathing could
eliminate both footrot and its causative agent, virulent D
nodosus, from an infected flock, as well as repeated
footbathing according to the conventional Swiss protocol
[39] and selective treatments did.
Our findings implicate that the real-time PCR test will
be of benefit as a diagnostic tool in elimination and sur-
veillance programs, as it identifies carriers before clinical
signs are manifest. This may reduce the severity of an
outbreak, because early intervention is possible, and will
lead to improved animal welfare and reduced losses.
Additionally, it allows the discrimination between early
stages of footrot and interdigital lesions of other origin,
which helps to reduce antimicrobial treatments to a
minimum.
Methods
Study groups
Thirty sheep farms were selected from clients of either
Schafpraxis or the Sheep Flock Health Service in Baden-
Württemberg in Southern Germany. The farmers had
used different strategies to eliminate footrot, and flocks
were divided into three groups:
Group A: Flocks which had no cases of clinical footrot
in the past 10 years or longer and did not vaccinate
during this period.
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Group B: Flocks which were at least 2 years free from
clinical footrot. They had become free through
repeated individual treatments with antimicrobials
(long-acting oxytetracycline, erythromycin, florfenicol),
repeated zinc sulphate footbaths (Golden Hoof plus®,
Sheepfair Products) and separation of clinically affected
sheep from the flock. Visual whole-flock hoof-screening
was operated within 1 day when new interdigital
inflammations were observed. Ahead of risky
weather periods, the whole flock was immunised
with a commercial vaccine (Footvax®, MSD Animal
Health) [40].
Group C: Flocks which became clinically free by a
single systemic whole-flock antimicrobial treatment. If
an animal did not clinically heal within 21 days, it was
treated a second time, non-responders were culled [23].
Seven of the selected flocks had used gamithromycin
(Zactran®, Boehringer Ingelheim), two had used
erythromycin (Erythrocin vet. 200®, Ceva Animal
Health) and one flock had used both products for the
elimination process. All flocks of this group proved to
have overcome at least three challenging weather
conditions without clinical signs of reinfection.
After the elimination of footrot, the only treatment in
all three groups were single zinc sulphate footbaths after
potential contact with infected flocks/sheep. The farms
were regularly visited by the farm vet (at least every third
month), and lameness assessments were undertaken.
The farmers performed detailed hoof checks of the
whole flock (every hoof of every sheep) during routine
hoof trimming.
For each group, 10 flocks were selected by conveni-
ence sampling. The selected flocks had an average size
of 650 sheep (ranging 70 to 2800 sheep) of Merino
Landschaf and Merino Landschaf mixed breeds.
As this was a field study, all participating animals
stayed in the production chain after the trial and were
not harmed.
Sampling
The present study was double-blinded for grouping of
the flock (sampling person) and the clinical outcome
(laboratory). To detect D nodosus with a probability of
more than 95% within a flock, the required sample size
was calculated to be 30 for each flock (27 for one be-
cause of its smaller flock size, based on a PCR specificity
for aprV2 of 98% and a sensitivity of 90% [41].
The sampling took place in May and June 2018. All
samples were processed and analysed in a single labora-
tory (Institute of Veterinary Bacteriology, University of
Bern, Switzerland). Interdigital swabs were collected from
all four feet of 30 sheep on each farm (27 on the smallest).
In order to improve sensitivity, the flock was sampled
according to a risk-based sampling plan [41]. High-risk
animals were sampled first. These included clinically lame
or recently purchased sheep, sheep which had been to
shows or markets, and sheep with contact to other flocks.
Thereafter, moderate-risk sheep were sampled: rams,
sheep with claw health problems and sheep with poor
horn quality. Then, “non-risk” sheep were randomly se-
lected from the flock to gain the required sample size.
Each animal was identified by ear tag and sat down or
put in a hoof trimming chute for sampling. The inter-
digital space was manually cleaned from soil or straw if
necessary and scored according to the 0–5 footrot scoring
system of the Swiss Consulting and Health Service for
Small Ruminants [14], to assess the clinical free status.
For each sheep, new disposable gloves were worn to
avoid contamination. A cotton swab (2 mm 15 cm, Paul
Hartmann) was pulled through the interdigital space of
the first claw, quarter-rotated and pulled through the
second interdigital space, rotated again and proceeded
like this until all four feet were sampled. The swabs were
immediately placed for 1 min into a 96 deep-well plate
(KingFisher™ 96 well clear round bottom 2mL polypro-
pylene deep well plate, Thermo Fisher Scientific) con-
taining 1mL SV–lysis buffer (4M guanidinethiocyanate,
0.01M Tris–HCl pH 7.5, 1% β-mercapto-ethanol) and
afterwards discarded. For every flock, a new deep-well
plate was prepared to prevent contamination between
farms. Samples from the three pool-groups were sepa-
rated on the plate for the same reason. The plates were
sealed with a silicone cover (Thermo Fisher Scientific)
and stored dark at 4 °C until laboratory analysis at 1 to 4
weeks after sampling. In total, 897 sheep from 30 differ-
ent farms were sampled this way.
Sample processing and real-time PCR
For every flock 50 μl aliquots from ten four-feet-samples
(nine in the smallest flock) were pooled starting from
high-risk animals resulting in three flock-samples with
decreasing risk [41]. As a control, the VetMAX™ Xeno™
Internal Positive Control DNA (20.000 copies; Thermo
Fisher Scientific) was added to each pooled sample prior
to purification. The DNA was extracted as described [11],
using a semi-automatic extraction robot (KingFisher™ Duo
Prime, Thermo Fisher Scientific). The purified DNA sam-
ples were kept at −20 °C until PCR analysis.
The competitive real-time PCR [10] was performed in
order to detect aprV2 of virulent D nodosus and/or
aprB2 of benign D nodosus by use of the TaqMan™ Fast
Advanced Master Mix and primer probe mix for the IPC
(Thermo Fisher Scientific). If PCR-results of pools were
positive for virulent D nodosus, the ten individual animal
samples were PCR analysed individually to determine
the number of positive animals. The same was done for
pools with ambiguous results for the IPC.
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